Asymchem Laboratories Tianjin CoASLTY 69 ROC (Joel Greenblatt) % is 15.80% as of Mar. 2026, which is 49% below its 10-year median of 31.01. GuruFocus rates ASLTY with a GF Score™ of 69/100 and a GF Value™ of $3.90 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,325 Biotechnology companies, Asymchem Laboratories Tianjin Co ranks better than 85.96% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Asymchem Laboratories Tianjin Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 15.80%.
The historical rank and industry rank for Asymchem Laboratories Tianjin Co's ROC (Joel Greenblatt) % or its related term are showing as below:
ASLTY'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 14.57 Med: 31.01 Max: 61.82
Current: 15.21
During the past 13 years, Asymchem Laboratories Tianjin Co's highest ROC (Joel Greenblatt) % was 61.82%. The lowest was 14.57%. And the median was 31.01%.
ASLTY's ROC (Joel Greenblatt) % is ranked better than 85.96% of 1325
companies
in the Biotechnology industry
Industry Median: -297.52
vs ASLTY: 15.21
Asymchem Laboratories Tianjin Co (OTCPK:ASLTY) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asymchem Laboratories Tianjin Co ROC (Joel Greenblatt) % Chart
ASLTY vs VRTX, REGN, ALNY: ROC (Joel Greenblatt) % Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co ROC (Joel Greenblatt) % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's ROC (Joel Greenblatt) % falls into.
Asymchem Laboratories Tianjin Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 15.80% mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a ROC (Joel Greenblatt) % of 15.80% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Asymchem Laboratories Tianjin Co and its competitors. This is 49% below median its historical median of 31.01. Over the past decade, Asymchem Laboratories Tianjin Co's ROC (Joel Greenblatt) % has ranged from 14.57 to 61.82. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #186 out of 1325 companies in the Biotechnology industry, placing it in the top 14%.
Is Asymchem Laboratories Tianjin Co's ROC (Joel Greenblatt) % too high?
Asymchem Laboratories Tianjin Co's current ROC (Joel Greenblatt) % of 15.80% is 49% below median its 10-year median of 31.01. Over the past 10 years, this metric has ranged from a low of 14.57 to a high of 61.82. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #186 out of 1325 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's ROC (Joel Greenblatt) % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #186 out of 1325 companies for ROC (Joel Greenblatt) %. This places Asymchem Laboratories Tianjin Co in the top 14% of its industry — outperforming the majority of peers. Historically, Asymchem Laboratories Tianjin Co's own ROC (Joel Greenblatt) % has ranged from 14.57 to 61.82 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Asymchem Laboratories Tianjin Co and its competitors. Asymchem Laboratories Tianjin Co's current ROC (Joel Greenblatt) % is 15.80%, which is 49% below median its own 10-year median of 31.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.90, compared to a current price of $6.37 — trading 63.3% above its estimated fair value. The current ROC (Joel Greenblatt) % is 15.80%, which is 49% below median its 10-year median of 31.01. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current ROC (Joel Greenblatt) % is 15.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $6.37 is trading 63.3% above its estimated GF Value™ of $3.90.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
ROC (Joel Greenblatt) %: 15.80% (49% below median its 10-year median of 31.01)
GF Value™: $3.90 vs. price of $6.37 (63.3% above fair value)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Business Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score
Get the complete analysis for ASLTY
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 
